298 related articles for article (PubMed ID: 27226369)
1. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
2. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
3. Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.
Race B; Phillips K; Meade-White K; Striebel J; Chesebro B
J Virol; 2015 Jun; 89(11):6022-32. PubMed ID: 25810548
[TBL] [Abstract][Full Text] [Related]
4. Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.
Mahal SP; Jablonski J; Suponitsky-Kroyter I; Oelschlegel AM; Herva ME; Oldstone M; Weissmann C
PLoS Pathog; 2012; 8(6):e1002746. PubMed ID: 22685404
[TBL] [Abstract][Full Text] [Related]
5. Prions.
Prusiner SB
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13363-83. PubMed ID: 9811807
[TBL] [Abstract][Full Text] [Related]
6. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.
Donne DG; Viles JH; Groth D; Mehlhorn I; James TL; Cohen FE; Prusiner SB; Wright PE; Dyson HJ
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13452-7. PubMed ID: 9391046
[TBL] [Abstract][Full Text] [Related]
7. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
[TBL] [Abstract][Full Text] [Related]
8. Strain-dependent role of copper in prion disease through binding to histidine residues in the N-terminal domain of prion protein.
Hara H; Miyata H; Chida J; Sakaguchi S
J Neurochem; 2023 Nov; 167(3):394-409. PubMed ID: 37777338
[TBL] [Abstract][Full Text] [Related]
9. β-hairpin-mediated formation of structurally distinct multimers of neurotoxic prion peptides.
Gill AC
PLoS One; 2014; 9(1):e87354. PubMed ID: 24498083
[TBL] [Abstract][Full Text] [Related]
10. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
Xiao X; Yuan J; Zou WQ
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
[TBL] [Abstract][Full Text] [Related]
11. Prion therapeutics: Lessons from the past.
Shim KH; Sharma N; An SSA
Prion; 2022 Dec; 16(1):265-294. PubMed ID: 36515657
[TBL] [Abstract][Full Text] [Related]
12. Arg177 and Asp159 from dog prion protein slow liquid-liquid phase separation and inhibit amyloid formation of human prion protein.
Li XN; Gao Y; Li Y; Yin JX; Yi CW; Yuan HY; Huang JJ; Wang LQ; Chen J; Liang Y
J Biol Chem; 2023 Nov; 299(11):105329. PubMed ID: 37805139
[TBL] [Abstract][Full Text] [Related]
13. Zn(II) binding causes interdomain changes in the structure and flexibility of the human prion protein.
Gielnik M; Taube M; Zhukova L; Zhukov I; Wärmländer SKTS; Svedružić Ž; Kwiatek WM; Gräslund A; Kozak M
Sci Rep; 2021 Nov; 11(1):21703. PubMed ID: 34737343
[TBL] [Abstract][Full Text] [Related]
14. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
[TBL] [Abstract][Full Text] [Related]
15. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.
Cortez LM; Morrison AJ; Garen CR; Patterson S; Uyesugi T; Petrosyan R; Sekar RV; Harms MJ; Woodside MT; Sim VL
Protein Sci; 2022 Dec; 31(12):e4477. PubMed ID: 36254680
[TBL] [Abstract][Full Text] [Related]
16. Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra.
Baron GS; Hughson AG; Raymond GJ; Offerdahl DK; Barton KA; Raymond LD; Dorward DW; Caughey B
Biochemistry; 2011 May; 50(21):4479-90. PubMed ID: 21539311
[TBL] [Abstract][Full Text] [Related]
17. Channel Activities of the Full-Length Prion and Truncated Proteins.
Wu J; Wang X; Lakkaraju A; Sternke-Hoffmann R; Qureshi BM; Aguzzi A; Luo J
ACS Chem Neurosci; 2024 Jan; 15(1):98-107. PubMed ID: 38096481
[TBL] [Abstract][Full Text] [Related]
18. Mapping the early steps in the pH-induced conformational conversion of the prion protein.
Alonso DO; DeArmond SJ; Cohen FE; Daggett V
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2985-9. PubMed ID: 11248018
[TBL] [Abstract][Full Text] [Related]
19. Emergence and natural selection of drug-resistant prions.
Shorter J
Mol Biosyst; 2010 Jul; 6(7):1115-30. PubMed ID: 20422111
[TBL] [Abstract][Full Text] [Related]
20. Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein.
Wolschner C; Giese A; Kretzschmar HA; Huber R; Moroder L; Budisa N
Proc Natl Acad Sci U S A; 2009 May; 106(19):7756-61. PubMed ID: 19416900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
